Ageing, ACE2 deficiency and bad outcome in COVID-19

被引：19
作者：
Angeli, Fabio [5 ,6 ]
Reboldi, Gianpaolo [1 ,2 ]
Verdecchia, Paolo [3 ,4 ]
机构：
[1] Univ Perugia, Dept Med, Perugia, Italy
[2] Univ Perugia, Ctr Ric Clin & Traslazionale CERICLET, Perugia, Italy
[3] Hosp S Maria Misericordia, Fdn Umbra Cuore & Ipertensione ONLUS, Perugia, Italy
[4] Hosp S Maria Misericordia, Div Cardiol, Perugia, Italy
[5] Univ Insubria, Dept Med & Surg, Varese, Italy
[6] IRCCS Tradate, Maugeri Care & Res Inst, Dept Med & Cardiopulm Rehabil, Tradate, Italy
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2021年 / 59卷 / 10期
关键词：
D O I：
10.1515/cclm-2021-0658
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：1607 / 1609
页数：3
相关论文
共 50 条
[21]   ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery [J].
Lores, Enrique ;
Wysocki, Jan ;
Batlle, Daniel .
CLINICAL SCIENCE, 2020, 134 (21) :2791-2805
[22]   ACE2, a drug target for COVID-19 treatment? [J].
Liu, Yang ;
Huang, Huilian .
IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (02) :919-921
[23]   COVID-19 and Comorbid Hypertension: Is ACE2 the Culprit? [J].
Zhang, Ting ;
Zhong, Sen ;
Cao, Wenzhai .
PREHOSPITAL AND DISASTER MEDICINE, 2020, 35 (06) :700-701
[24]   COVID-19 susceptibility: potential of ACE2 polymorphisms [J].
Mayank Chaudhary .
Egyptian Journal of Medical Human Genetics, 21
[25]   A historical perspective on ACE2 in the COVID-19 era [J].
Vivek Bhalla ;
Catherine A. Blish ;
Andrew M. South .
Journal of Human Hypertension, 2021, 35 :935-939
[26]   Impact of ACE2 on the susceptibility and vulnerability to COVID-19 [J].
Pringle, Kirsty G. ;
Philp, Lisa K. .
JOURNAL OF ENDOCRINOLOGY, 2023, 258 (03)
[27]   COVID-19 infection: ACE2, pregnancy and preeclampsia [J].
Todros, Tullia ;
Masturzo, Bianca ;
De Francia, Silvia .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 253 :330-330
[28]   A historical perspective on ACE2 in the COVID-19 era [J].
Bhalla, Vivek ;
Blish, Catherine A. ;
South, Andrew M. .
JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (10) :935-939
[29]   The therapeutic potential of targeting ACE2 in COVID-19 [J].
Elmors, R. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (18) :9744-9747
[30]   Soluble ACE2 as a potential therapy for COVID-19 [J].
Krishnamurthy, Sudarshan ;
Lockey, Richard F. ;
Kolliputi, Narasaiah .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 320 (03) :C279-C281
12345